Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review
Abstract Glioblastoma (GBM) is a fatal brain tumour that is traditionally diagnosed based on histological features. Recent molecular profiling studies have reshaped the World Health Organization approach in the classification of central nervous system tumours to include more pathogenetic hallmarks....
| Príomhchruthaitheoirí: | , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
BMC
2024-04-01
|
| Sraith: | Experimental Hematology & Oncology |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s40164-024-00512-8 |